SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-008577
Filing Date
2022-05-12
Accepted
2022-05-12 16:31:22
Documents
53
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q mrns-20220331x10q.htm   iXBRL 10-Q 1087794
2 EX-3.8 mrns-20220331xex3d8.htm EX-3.8 10578
3 EX-31.1 mrns-20220331xex31d1.htm EX-31.1 13243
4 EX-31.2 mrns-20220331xex31d2.htm EX-31.2 13352
5 EX-32.1 mrns-20220331xex32d1.htm EX-32.1 7667
6 GRAPHIC mrns-20220331x10q007.jpg GRAPHIC 49267
7 GRAPHIC mrns-20220331x10q004.jpg GRAPHIC 14134
  Complete submission text file 0001558370-22-008577.txt   4934094

Data Files

Seq Description Document Type Size
8 EX-101.SCH mrns-20220331.xsd EX-101.SCH 39547
9 EX-101.CAL mrns-20220331_cal.xml EX-101.CAL 46466
10 EX-101.DEF mrns-20220331_def.xml EX-101.DEF 147236
11 EX-101.LAB mrns-20220331_lab.xml EX-101.LAB 344260
12 EX-101.PRE mrns-20220331_pre.xml EX-101.PRE 242548
47 EXTRACTED XBRL INSTANCE DOCUMENT mrns-20220331x10q_htm.xml XML 716660
Mailing Address 5 RADNOR CORPORATE CENTER SUITE 500 100 MATSONFORD RD RADNOR PA 19087
Business Address 5 RADNOR CORPORATE CENTER SUITE 500 100 MATSONFORD RD RADNOR PA 19087 484-801-4670
MARINUS PHARMACEUTICALS, INC. (Filer) CIK: 0001267813 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36576 | Film No.: 22918360
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences